| Radiomics: the bridge between medical imaging and personalized medicine | 2017/10/04 | English | 2,829 |
| Tumour-associated macrophages as treatment targets in oncology | 2017/01/24 | English | 2,365 |
| Delivering nanomedicine to solid tumors | 2010/09/14 | English | 2,195 |
| Tumour heterogeneity and resistance to cancer therapies | 2017/11/08 | English | 1,805 |
| Clinical development and potential of photothermal and photodynamic therapies for cancer | 2020/07/22 | English | 1,632 |
| Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease | 2016/05/17 | English | 1,618 |
| Targeting the IL-6/JAK/STAT3 signalling axis in cancer | 2018/02/06 | English | 1,609 |
| EMT, CSCs, and drug resistance: the mechanistic link and clinical implications | 2017/04/11 | English | 1,572 |
| Chimeric antigen receptor T-cell therapy — assessment and management of toxicities | 2017/09/19 | English | 1,456 |
| The immune contexture in cancer prognosis and treatment | 2017/07/25 | English | 1,306 |
| Liquid biopsy: monitoring cancer-genetics in the blood | 2013/07/09 | English | 1,190 |
| Broadening horizons: the role of ferroptosis in cancer | 2021/01/29 | English | 1,185 |
| Integrating liquid biopsies into the management of cancer | 2017/03/02 | English | 1,172 |
| Molecular therapies and precision medicine for hepatocellular carcinoma | 2018/07/30 | English | 1,151 |
| Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance | 2019/05/15 | English | 1,126 |
| Targeting apoptosis in cancer therapy | 2020/03/23 | English | 1,116 |
| Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges | 2018/03/06 | English | 1,114 |
| MicroRNAs in body fluids—the mix of hormones and biomarkers | 2011/06/07 | English | 1,019 |
| Cancer immunoediting and resistance to T cell-based immunotherapy | 2018/12/06 | English | 999 |
| Cholangiocarcinoma — evolving concepts and therapeutic strategies | 2017/10/10 | English | 934 |
| Extracellular vesicles in cancer — implications for future improvements in cancer care | 2018/05/23 | English | 927 |
| Image-guided cancer surgery using near-infrared fluorescence | 2013/07/23 | English | 923 |
| NTRK fusion-positive cancers and TRK inhibitor therapy | 2018/10/17 | English | 897 |
| Patient-derived tumour xenografts as models for oncology drug development | 2012/04/17 | English | 879 |
| Cancer-related fatigue—mechanisms, risk factors, and treatments | 2014/08/12 | English | 877 |
| Cancer metabolism: a therapeutic perspective | 2016/05/04 | English | 842 |
| Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update | 2015/04/07 | English | 837 |
| Targeted agents and immunotherapies: optimizing outcomes in melanoma | 2017/04/04 | English | 808 |
| Regulatory T cells in cancer immunosuppression — implications for anticancer therapy | 2019/01/31 | English | 791 |
| EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood | 2020/12/08 | English | 779 |